PATH defends itself against Indian criticisms of HPV project (2013)

Other · FiercePharma · September 4, 2013

Trade-press account of PATH's response to the 72nd report, in which PATH called the committee's conclusions an inaccurate characterization and pointed to ICMR's designation of the work as a post-licensure observational study.

inaccurate characterization

Trade-press account of PATH's response to the 72nd report, in which PATH called the committee's conclusions an inaccurate characterization and pointed to ICMR's designation of the work as a post-licensure observational study. Records PATH's rebuttal alongside the parliamentary findings for balance.

Election Day is Tuesday, Nov 3. Know who you're voting for: your values vs. their record, with sources.Build my Vote Card →